Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.

@article{Lanni2011StereotacticRR,
  title={Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.},
  author={Thomas B. Lanni and Inga Siiner Grills and Larry Llyn Kestin and John M Robertson},
  journal={American journal of clinical oncology},
  year={2011},
  volume={34 5},
  pages={494-8}
}
PURPOSE Radiation therapy (RT) is the standard alternative curative treatment option for medically inoperable early stage non-small-cell lung cancer (NSCLC). Recently, stereotactic body radiotherapy (SBRT) has shown substantial promise to improve local control rates as compared with conventional fractionated RT [external beam RT (EBRT)]. We compare treatment outcomes and costs between SBRT and EBRT in this patient population. MATERIALS AND METHODS A total of 86 patients with Stage I (Tl-2 N0… CONTINUE READING